Browse Companies
Discover companies hiring across Latin America
Loading companies...
Discover companies hiring across Latin America
Showing 1 to 3 of 3 companies
Precision for Medicine is a global clinical research organization (CRO) that specializes in biomarker-driven research and development services for life sciences companies, focusing on oncology, rare diseases, and precision medicine. As part of the Precision Medicine Group, it employs 3,500 experts across 40 locations worldwide. The company integrates clinical operations, laboratory expertise, and advanced data sciences to enhance drug development from early stages through to approval. The company offers a comprehensive range of services, including clinical trial management, biospecimen and sample management, laboratory and analytical services, and consulting. Its capabilities support complex trials with a focus on real-time processing and data integration. Precision for Medicine also provides high-quality human biospecimens and custom-processed samples, along with analytical outputs that aid in the development of in vitro diagnostics. Recognized for its innovative solutions in drug development, the company emphasizes collaborative and agile approaches to optimize clinical trial design and execution.
Precision Medicine Group is a specialty services company founded in 2012, headquartered in Bethesda, Maryland. It supports pharmaceutical and life sciences clients at every stage of product development and commercialization, operating across 35 locations in North America, Europe, and Asia-Pacific. The company consists of two main platforms. Precision for Medicine offers biomarker-driven research and development, providing clinical research organization (CRO) services, laboratory expertise, and AI-enabled data solutions. Precision AQ focuses on commercialization services, assisting life science organizations from product launch through maturity. Precision Medicine Group aims to enhance the drug development process by integrating science, technology, data, and human expertise to drive commercial success.
Syneos Health is a fully integrated biopharmaceutical solutions organization formed in 2018 through the merger of INC Research and InVentiv Health. With over 26,000 employees across more than 110 countries, the company focuses on synchronizing clinical development and commercial execution for biopharmaceutical clients. Syneos Health leverages AI and technology to enhance customer success, translating insights into outcomes while addressing the challenges of product lifecycles from preclinical stages to market launch. The company offers comprehensive biopharmaceutical solutions that include clinical development, commercialization, and consulting services. Its expertise spans various therapeutic areas, including oncology, central nervous system, and immunology. Syneos Health Consulting provides advisory services across the drug development lifecycle, supporting portfolio strategy, medical affairs, and risk management. The firm has played a significant role in the development and commercialization of a high percentage of novel drugs, contributing to the approval of numerous FDA and EMA products.